CompletedPhase 2NCT02048644

Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hull University Teaching Hospitals NHS Trust
Principal Investigator
Simon Hart, MD
Hull University Teaching Hospitals NHS Trust
Intervention
fostair(drug)
Enrollment
20 enrolled
Eligibility
40-85 years · All sexes
Timeline
2014 – 2015

Study locations (1)

Collaborators

Chiesi Farmaceutici S.p.A.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02048644 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials